Cargando…
Weighing Potential Benefits and Harms of Mycoplasma genitalium Testing and Treatment Approaches
Since Mycoplasma genitalium was identified 40 years ago, much of the epidemiology has been described, diagnostic tests have been developed and approved, and recommended treatment approaches have been identified. However, the natural history remains incompletely understood, and antimicrobial resistan...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328920/ https://www.ncbi.nlm.nih.gov/pubmed/35876565 http://dx.doi.org/10.3201/eid2808.220094 |
_version_ | 1784757823625756672 |
---|---|
author | Manhart, Lisa E. Geisler, William M. Bradshaw, Catriona S. Jensen, Jørgen S. Martin, David H. |
author_facet | Manhart, Lisa E. Geisler, William M. Bradshaw, Catriona S. Jensen, Jørgen S. Martin, David H. |
author_sort | Manhart, Lisa E. |
collection | PubMed |
description | Since Mycoplasma genitalium was identified 40 years ago, much of the epidemiology has been described, diagnostic tests have been developed and approved, and recommended treatment approaches have been identified. However, the natural history remains incompletely understood, and antimicrobial resistance has rapidly increased. This review summarizes evidence published since the US Centers for Disease Control and Prevention 2015 Sexually Transmitted Diseases Treatment Guidelines. Data on sequelae remain insufficient, macrolide resistance is common, and fluoroquinolone resistance is increasing. Potential benefits of testing and treatment include resolving symptoms, interrupting transmission, and preventing sequelae. Potential harms include cost, patient anxiety, and increasing antimicrobial resistance. |
format | Online Article Text |
id | pubmed-9328920 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-93289202022-08-06 Weighing Potential Benefits and Harms of Mycoplasma genitalium Testing and Treatment Approaches Manhart, Lisa E. Geisler, William M. Bradshaw, Catriona S. Jensen, Jørgen S. Martin, David H. Emerg Infect Dis Online Report Since Mycoplasma genitalium was identified 40 years ago, much of the epidemiology has been described, diagnostic tests have been developed and approved, and recommended treatment approaches have been identified. However, the natural history remains incompletely understood, and antimicrobial resistance has rapidly increased. This review summarizes evidence published since the US Centers for Disease Control and Prevention 2015 Sexually Transmitted Diseases Treatment Guidelines. Data on sequelae remain insufficient, macrolide resistance is common, and fluoroquinolone resistance is increasing. Potential benefits of testing and treatment include resolving symptoms, interrupting transmission, and preventing sequelae. Potential harms include cost, patient anxiety, and increasing antimicrobial resistance. Centers for Disease Control and Prevention 2022-08 /pmc/articles/PMC9328920/ /pubmed/35876565 http://dx.doi.org/10.3201/eid2808.220094 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Online Report Manhart, Lisa E. Geisler, William M. Bradshaw, Catriona S. Jensen, Jørgen S. Martin, David H. Weighing Potential Benefits and Harms of Mycoplasma genitalium Testing and Treatment Approaches |
title | Weighing Potential Benefits and Harms of Mycoplasma genitalium Testing and Treatment Approaches |
title_full | Weighing Potential Benefits and Harms of Mycoplasma genitalium Testing and Treatment Approaches |
title_fullStr | Weighing Potential Benefits and Harms of Mycoplasma genitalium Testing and Treatment Approaches |
title_full_unstemmed | Weighing Potential Benefits and Harms of Mycoplasma genitalium Testing and Treatment Approaches |
title_short | Weighing Potential Benefits and Harms of Mycoplasma genitalium Testing and Treatment Approaches |
title_sort | weighing potential benefits and harms of mycoplasma genitalium testing and treatment approaches |
topic | Online Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328920/ https://www.ncbi.nlm.nih.gov/pubmed/35876565 http://dx.doi.org/10.3201/eid2808.220094 |
work_keys_str_mv | AT manhartlisae weighingpotentialbenefitsandharmsofmycoplasmagenitaliumtestingandtreatmentapproaches AT geislerwilliamm weighingpotentialbenefitsandharmsofmycoplasmagenitaliumtestingandtreatmentapproaches AT bradshawcatrionas weighingpotentialbenefitsandharmsofmycoplasmagenitaliumtestingandtreatmentapproaches AT jensenjørgens weighingpotentialbenefitsandharmsofmycoplasmagenitaliumtestingandtreatmentapproaches AT martindavidh weighingpotentialbenefitsandharmsofmycoplasmagenitaliumtestingandtreatmentapproaches |